MOORE CAPITAL MANAGEMENT, LP - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,659,000
+4.4%
105,0000.0%0.03%
+14.8%
Q2 2023$1,589,700
+4.4%
105,0000.0%0.03%
-15.6%
Q1 2023$1,522,500
+7.2%
105,0000.0%0.03%
-5.9%
Q4 2022$1,419,600
-14.2%
105,0000.0%0.03%
-12.8%
Q3 2022$1,655,000
+29.4%
105,0000.0%0.04%
+14.7%
Q2 2022$1,279,000
+29.7%
105,0000.0%0.03%
+36.0%
Q1 2022$986,000
-45.2%
105,0000.0%0.02%
-30.6%
Q4 2021$1,798,000105,0000.04%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders